For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Summary
Contrast agents are chemicals, which are used to enhance the image effect to observe
By injecting (or taking) into human tissue or organs. The density of contrast agents is higher or lower than surrounding tissue and this contrast can display images via some device. Contrast agents are widely used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Contrast Agents , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and By major regions).
The report provides introduction of leading Global manufacturers.
Contrast Agents market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc)
- Asia-Pacific (China, India, Japan, Southeast Asia etc)
- South America (Brazil, Argentina etc)
- Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
- High Density Contrast Agents
- Low Density Contrast Agents
By End-User / Application
- X-CT
- MRI
- Others
By Company
- Bayer
- GE Healthcare
- Bracco Imaging
- Guerbet Group
- Hengrui Medicine
- YRPG
- Lantheus
- BeiLu Pharma